Download PDF
Thromb Haemost 2001; 86(04): 1125-1126
DOI: 10.1055/s-0037-1616549
Letters to the Editor
Schattauer GmbH

Experiences with Recombinant Factor VIIa for the Prevention of Bleeding in Patients with Chronic Liver Disease Undergoing Percutaneous Liver Biopsies and Endoscopic Retrograde Cholangiopancreatography (ERCP)

Chomsri Kositchaiwat
1   Division of Gastroenterology and Tropical Medicine, Department of Medicine, Mahidol University, Bangkok, Thailand
,
Ampaiwan Chuansumrit
2   Division of Hematology, Department of Paediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
› Author Affiliations
Further Information

Publication History

Received 09 April 2001

Accepted 09 April 2001

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Brophy MT, Fiore LD, Deykin D. Hemostasis. In: Hepatology. A textbook of liver disease. 3rd ed. Zakim D, Boyer TD. eds. Pensylvania: W. B. Saunders Company; 1996: 706-7.
    Google Scholar
  • 2 Bernstein DE, Jeffer L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, Bech R, Hedner U, Schiff ER. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterol 1997; 113: 1930-7.
    CrossrefPubMedGoogle Scholar
  • 3 Kalicinski P, Kaminski A, Drewniak T, Ismail H, Szymczak M, Markiewicz M, Lukasiewicz H. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplantation Proceedings 1999; 31: 378-9.
    CrossrefPubMedGoogle Scholar